StemCells, Inc., Pathway™ Study in Cervical Spinal Cord Injury Featured in The Downey Patriot
Mar 30, 2016 20:13 pm UTC| Business
NEWARK, Calif., March 30, 2016 -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system disorders, today announced the...
Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference
Mar 30, 2016 20:10 pm UTC| Business
PRINCETON, N.J., March 30, 2016 -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products,...
Sphere 3D Reports Fourth Quarter and Fiscal Year 2015 Financial Results
Mar 30, 2016 20:07 pm UTC| Business
SAN JOSE, Calif., March 30, 2016 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, today reported financial results for its fourth quarter and fiscal year ended...
Micron Technology, Inc., Reports Results for the Second Quarter of Fiscal 2016
Mar 30, 2016 20:06 pm UTC| Business
BOISE, Idaho, March 30, 2016 -- Micron Technology, Inc., (NASDAQ:MU) today announced results of operations for its second quarter of fiscal 2016, which ended March 3, 2016. Revenues for the second quarter of fiscal 2016...
Vitae Pharmaceuticals Closes Public Offering of Common Stock
Mar 30, 2016 20:05 pm UTC| Business
FORT WASHINGTON, Pa., March 30, 2016 -- Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), a clinical-stage biotechnology company, today announced the completion of its underwritten public offering of 5,833,333 shares of its...
SPAR Group Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2015
Mar 30, 2016 20:05 pm UTC| Business
WHITE PLAINS, N.Y., March 30, 2016 -- SPAR Group, Inc. (Nasdaq:SGRP), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced financial...
BeiGene Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 30, 2016 20:05 pm UTC| Business
WALTHAM, Mass., March 30, 2016 -- BeiGene, Ltd. (NASDAQ:BGNE) (“BeiGene”), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of...